• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转录酶骨架可改变非核苷逆转录酶突变体 K101E+G190S 的聚合和 RNase 活性。

Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.

机构信息

University of Rochester, School of Medicine and Dentistry, Department of Medicine, Rochester, NY, USA.

University of Rochester, School of Medicine and Dentistry, Department of Microbiology and Immunology, Rochester, NY, USA.

出版信息

J Gen Virol. 2013 Oct;94(Pt 10):2297-2308. doi: 10.1099/vir.0.054999-0. Epub 2013 Jun 26.

DOI:10.1099/vir.0.054999-0
PMID:23804564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3785032/
Abstract

Previous work by our group showed that human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing non-nucleoside RT inhibitor (NNRTI) drug resistance mutations has defects in RNase H activity as well as reduced amounts of RT protein in virions. These deficits correlate with replication fitness in the absence of NNRTIs. Viruses with the mutant combination K101E+G190S replicated better in the presence of NNRTIs than in the absence of drug. Stimulation of virus growth by NNRTIs occurred during the early steps of the virus life cycle and was modulated by the RT backbone sequence in which the resistance mutations arose. We wanted to determine what effects RT backbone sequence would have on RT content and polymerization and RNase H activities in the absence of NNRTIs. We compared a NL4-3 RT with K101E+G190S to a patient-isolate RT sequence D10 with K101E+G190S. We show here that, unlike the NL4-3 backbone, the D10 backbone sequence decreased the RNA-dependent DNA polymerization activity of purified recombinant RT compared to WT. In contrast, RTs with the D10 backbone had increased RNase H activity compared to WT and K101E+G190S in the NL4-3 backbone. D10 virions also had increased amounts of RT compared to K101E+G190S in the NL4-3 backbone. We conclude that the backbone sequence of RT can alter the activities of the NNRTI drug-resistant mutant K101E+G190S, and that identification of the amino acids responsible will aid in understanding the mechanism by which NNRTI drug-resistant mutants alter fitness and NNRTIs stimulate HIV-1 virus replication.

摘要

先前我们小组的工作表明,含有非核苷类逆转录酶抑制剂(NNRTI)耐药突变的人类免疫缺陷病毒 1 型(HIV-1)逆转录酶(RT)在 RNase H 活性以及病毒粒子中的 RT 蛋白含量方面存在缺陷。这些缺陷与缺乏 NNRTI 时的复制适应性相关。与野生型相比,含有突变组合 K101E+G190S 的病毒在存在 NNRTI 时的复制能力更好。NNRTI 对病毒生长的刺激发生在病毒生命周期的早期阶段,并且受耐药突变出现的 RT 骨架序列调节。我们想确定 RT 骨架序列在缺乏 NNRTI 时对 RT 含量、聚合和 RNase H 活性的影响。我们比较了含有 K101E+G190S 的 NL4-3 RT 与含有 K101E+G190S 的患者分离株 RT 序列 D10。我们在这里表明,与 NL4-3 骨架不同,与野生型相比,D10 骨架序列降低了纯化重组 RT 的 RNA 依赖性 DNA 聚合活性。相比之下,与 NL4-3 骨架中的野生型和 K101E+G190S 相比,含有 D10 骨架的 RT 的 RNase H 活性增加。与 NL4-3 骨架中的 K101E+G190S 相比,D10 病毒粒子中的 RT 含量也增加。我们得出结论,RT 的骨架序列可以改变 NNRTI 耐药突变体 K101E+G190S 的活性,确定负责的氨基酸将有助于理解 NNRTI 耐药突变体如何改变适应性以及 NNRTI 如何刺激 HIV-1 病毒复制的机制。

相似文献

1
Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.逆转录酶骨架可改变非核苷逆转录酶突变体 K101E+G190S 的聚合和 RNase 活性。
J Gen Virol. 2013 Oct;94(Pt 10):2297-2308. doi: 10.1099/vir.0.054999-0. Epub 2013 Jun 26.
2
L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness.L74V 增加了含有非核苷类逆转录酶耐药突变 L100I+K103N 和 K101E+G190S 的 HIV-1 病毒粒子中的逆转录酶含量,从而导致适应性增加。
J Gen Virol. 2013 Jul;94(Pt 7):1597-1607. doi: 10.1099/vir.0.050914-0. Epub 2013 Mar 27.
3
The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations.非核苷类逆转录酶抑制剂依非韦伦可刺激携带某些非核苷耐药突变的人类免疫缺陷病毒 1 型的复制。
Virology. 2010 Jul 5;402(2):228-37. doi: 10.1016/j.virol.2010.03.018. Epub 2010 Apr 18.
4
Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.具有非核苷类逆转录酶抑制剂耐药突变的 HIV-1 在细胞培养中的适应性降低与病毒粒子中逆转录酶含量和 RNase H 活性的相对水平相关。
J Virol. 2010 Sep;84(18):9377-89. doi: 10.1128/JVI.00618-10. Epub 2010 Jun 30.
5
Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection.非核苷类逆转录酶抑制剂耐药的 HIV 在感染早期受到依非韦伦的刺激。
J Virol. 2011 Oct;85(20):10861-73. doi: 10.1128/JVI.05116-11. Epub 2011 Aug 10.
6
The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNA(Lys, 3) that correlate with reductions in replication efficiency.对非核苷类逆转录酶抑制剂产生耐药性的HIV-1逆转录酶突变体G190S和G190A,其核糖核酸酶H活性降低,且从tRNA(Lys,3)起始的DNA合成减少,这与复制效率降低相关。
Virology. 2006 May 10;348(2):462-74. doi: 10.1016/j.virol.2006.01.014. Epub 2006 Feb 28.
7
Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture.对非核苷类逆转录酶抑制剂具有抗性的人类免疫缺陷病毒1型(HIV-1)逆转录酶突变体表现出核糖核酸酶H切割速率的改变,这与HIV-1在细胞培养中的复制适应性相关。
J Virol. 2000 Sep;74(18):8390-401. doi: 10.1128/jvi.74.18.8390-8401.2000.
8
The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.P236L地拉韦定耐药的1型人类免疫缺陷病毒突变体复制存在缺陷,并且在RNA 5'端和DNA 3'端导向的核糖核酸酶H活性方面均表现出改变。
J Virol. 1999 Jul;73(7):5803-13. doi: 10.1128/JVI.73.7.5803-5813.1999.
9
Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors.K101E 取代在 HIV-1 逆转录酶中对利匹韦林和其他非核苷类逆转录酶抑制剂耐药中的作用。
Antimicrob Agents Chemother. 2013 Nov;57(11):5649-57. doi: 10.1128/AAC.01536-13. Epub 2013 Sep 3.
10
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.1型人类免疫缺陷病毒逆转录酶第190位密码子上由非核苷类逆转录酶抑制剂(NNRTI)选择的突变降低了对司他夫定和齐多夫定的敏感性。
Antiviral Res. 2007 Nov;76(2):99-103. doi: 10.1016/j.antiviral.2007.06.002. Epub 2007 Jul 2.

引用本文的文献

1
The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy.长期含奈韦拉平抗病毒治疗中耐药突变 K103N Y181C 和 G190A 的发展。
AIDS Res Ther. 2014 Nov 21;11:36. doi: 10.1186/1742-6405-11-36. eCollection 2014.

本文引用的文献

1
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance.HIV-1 型 C 亚型治疗耐药患者的连接子结构域突变增强了 NRTI 和 NNRTI 耐药性。
Virology. 2013 Jan 20;435(2):433-41. doi: 10.1016/j.virol.2012.09.021. Epub 2012 Oct 13.
2
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.临床、病毒学和生物化学证据支持 HIV-1 逆转录酶多态性 R284K 与替诺福韦/恩曲他滨治疗失败患者中胸苷类似物耐药突变 M41L、L210W 和 T215Y 的关联。
Retrovirology. 2012 Aug 13;9:68. doi: 10.1186/1742-4690-9-68.
3
HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors.HIV-1 逆转录酶(RT)的 172K 多态性抑制了临床相关的核苷和非核苷 RT 抑制剂耐药突变的效果。
J Biol Chem. 2012 Aug 24;287(35):29988-99. doi: 10.1074/jbc.M112.351551. Epub 2012 Jul 2.
4
Rilpivirine and complera: new first-line treatment options.利匹韦林和复方制剂:新的一线治疗选择。
BETA. 2011 Fall-Winter;23(4):14-8.
5
Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives.新型 6-取代 1-苄基-3-(3,5-二甲基苄基)尿嘧啶衍生物的抗人类免疫缺陷病毒 1 型活性。
Antimicrob Agents Chemother. 2012 May;56(5):2581-9. doi: 10.1128/AAC.06307-11. Epub 2012 Jan 30.
6
HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies.HIV 类型、组、亚型和重组形式:复制错误、选择压力和准种。
Intervirology. 2012;55(2):79-83. doi: 10.1159/000331993. Epub 2012 Jan 24.
7
2011 update of the drug resistance mutations in HIV-1.2011年人类免疫缺陷病毒1型耐药性突变的更新情况
Top Antivir Med. 2011 Nov;19(4):156-64.
8
Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.人类免疫缺陷病毒逆转录酶 p51 亚单位的突变定义了残基,这些残基有助于乙烯脲抑制核糖核酸酶 H 活性。
J Biol Chem. 2012 Feb 3;287(6):4066-75. doi: 10.1074/jbc.M111.314781. Epub 2011 Nov 21.
9
Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines.疾病控制与预防中心性传播疾病治疗指南
Clin Infect Dis. 2011 Dec;53 Suppl 3:S59-63. doi: 10.1093/cid/cir694.
10
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.HIV-1 核糖核酸酶 H:结构、催化机制与抑制剂。
Viruses. 2010 Apr;2(4):900-926. doi: 10.3390/v2040900. Epub 2010 Mar 30.